Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.

Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.

PharmacoEconomics (2017-09-16)

Irina A Tikhonova, Tracey Jones-Hughes, James Dunham, Fiona C Warren, Sophie Robinson, Peter Stephens, Martin Hoyle

ABSTRAKT

The manufacturer of olaratumab (Lartruvo

MATERIAŁY

Numer produktu

Marka

Opis produktu

Sigma-Aldrich

N,O-Bis(trimethylsilyl)carbamate, ≥98.0% (T)